Elevance Health, Inc. (LON:0HG8)
London · Delayed Price · Currency is GBP · Price in USD 315.05
+6.16 (2.00%)
At close: Aug 29, 2025
Elevance Health Market Cap
Elevance Health has a market cap or net worth of 53.12 billion as of August 29, 2025. Its market cap has decreased by -45.44% in one year.
Market Cap
53.12B
Enterprise Value
69.22B
Revenue
138.14B
Ranking
n/a
PE Ratio
13.58
Stock Price
315.05
Market Cap Chart
Since October 30, 2001, Elevance Health's market cap has increased from 2.89B to 53.12B, an increase of 1,736.61%. That is a compound annual growth rate of 12.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 53.12B | -22.27% |
| Dec 31, 2024 | 68.34B | -21.43% |
| Dec 29, 2023 | 86.98B | -14.45% |
| Dec 30, 2022 | 101.68B | 22.37% |
| Dec 31, 2021 | 83.09B | 42.06% |
| Dec 31, 2020 | 58.49B | 1.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 184.16B |
| GSK plc | 59.21B |
| Haleon | 32.48B |
| Smith & Nephew | 12.02B |
| ConvaTec Group | 4.77B |
| Hikma Pharmaceuticals | 4.03B |
| HUTCHMED (China) | 1.94B |
| Oxford Nanopore Technologies | 1.92B |